Multimodal biometric authentication for VR/AR using EEG and eye tracking V Krishna, Y Ding, A Xu, T Höllerer Adjunct of the 2019 International Conference on Multimodal Interaction, 1-5, 2019 | 22 | 2019 |
Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer V Nimgaonkar, V Krishna, V Krishna, E Tiu, A Joshi, D Vrabac, ... Cell Reports Medicine 4 (4), 2023 | 15 | 2023 |
Application of deep learning and image processing analysis of photographs for amblyopia screening K Murali, V Krishna, V Krishna, B Kumari Indian Journal of Ophthalmology 68 (7), 1407-1410, 2020 | 15 | 2020 |
Effectiveness of Kanna photoscreener in detecting amblyopia risk factors K Murali, V Krishna, V Krishna, B Kumari, SR Murthy, C Vidhya, P Shah Indian Journal of Ophthalmology 69 (8), 2054-2049, 2021 | 9 | 2021 |
Techniques for identifying blepharoptosis from an image V Krishna, V Krishna US Patent 10,580,133, 2020 | 7 | 2020 |
Development and validation of RP‐HPLC for assay of lacosamide injection N Jayasimha, VR Krishna, V Sandeep, ESK Goud World Journal of Pharmacy and Pharmaceutical Sciences 4 (02), 1067-1074, 2015 | 6 | 2015 |
LymphoML: An interpretable artificial intelligence-based method identifies morphologic features that correlate with lymphoma subtype V Shankar, X Yang, V Krishna, B Tan, O Silva, R Rojansky, A Ng, ... Machine Learning for Health (ML4H), 528-558, 2023 | 4 | 2023 |
Gemcitabine response prediction in the adjuvant treatment of resected pancreatic ductal adenocarcinoma using an AI histopathology platform. V Krishna, V Nimgaonkar, E Tiu, V Krishna, H Bhambhvani, S Cook, ... Journal of Clinical Oncology 40 (16_suppl), e16295-e16295, 2022 | 2 | 2022 |
Predicting Response to Intravesical BCG in High-Risk NMIBC Using an Artificial Intelligence-Powered Pathology Assay: Development and Validation in an International 12-Center … Y Lotan, V Krishna, WM Abuzeid, B Launer, SS Chang, V Krishna, ... J Urol, 101097JU0000000000004278, 2024 | 1 | 2024 |
Abstract A043: Validation of an artificial intelligence derived histological biomarker for gemcitabine response in resected pancreatic ductal adenocarcinoma (PDAC) V Krishna, V Krishna, E Tiu, V Nimgaonkar, D Vrabac, K Smith, A Joshi, ... Cancer Research 82 (22_Supplement), A043-A043, 2022 | 1 | 2022 |
1773P Prediction of neoadjuvant chemotherapy response in muscle-invasive bladder cancer: A machine learning approach E Shkolyar, H Bhambhvani, E Tiu, V Krishna, V Nimgaonkar, R Krishnan, ... Annals of Oncology 33, S1348, 2022 | 1 | 2022 |
Histological changes in the trachea and lung of the foetal goat. VR Krishna, GP Tiwari, KC Vaish | 1 | 1982 |
PD27-12 DEVELOPMENT AND VALIDATION OF GENERALIZABLE INTERPRETABLE AI BIOMARKERS TO PREDICT CLINICAL OUTCOMES IN BCG-TREATED PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER Y Lotan, JB Shah, V Krishna, B Launer, V Krishna, S Shingi, J Gordetsky, ... Journal of Urology 211 (5S), e555, 2024 | | 2024 |
Predicting response to intravesical BCG in high-risk non-muscle invasive bladder cancer using an artificial intelligence-powered pathology assay: development and validation in … Y Lotan, V Krishna, WM Abuzeid, B Launer, SS Chang, V Krishna, ... Journal of Urology, 10.1097, 2024 | | 2024 |
AI-based pathologic biomarker for pathologic downstaging in patients with muscle-invasive bladder cancer undergoing cystectomy after neoadjuvant nivolumab, gemcitabine, and … V Krishna, GP Sonpavde, S Gupta, BL Maughan, N Agarwal, M Eckstein, ... Journal of Clinical Oncology 41 (16_suppl), e16566-e16566, 2023 | | 2023 |
Development of artificial intelligence–derived histological biomarkers for first-line treatment selection in metastatic pancreatic ductal adenocarcinoma (mPDAC). V Krishna, E Tiu, V Krishna, D Vrabac, K Shah, W Abuzeid, K Smith, ... Journal of Clinical Oncology 41 (4_suppl), 743-743, 2023 | | 2023 |
43/# 512 Assessing robustness of an artificial intelligence derived histological biomarker across different sites of disease and in serial sections in tubo-ovarian high-grade … R Krishnan, E Tiu, V Krishna, V Nimgaonkar, H Bhambhvani, ... International Journal of Gynecologic Cancer 32 (Suppl 3), 2022 | | 2022 |
44/# 219 Predicting response to platinum-based chemotherapy for tubo-ovarian high-grade serous carcinoma using an artificial intelligence histopathology platform E Tiu, V Krishna, V Nimgaonkar, R Krishnan, H Bhambhvani, ... International Journal of Gynecologic Cancer 32 (Suppl 3), 2022 | | 2022 |
Validation of an artificial intelligence derived histological biomarker for gemcitabine response in resected pancreatic ductal adenocarcinoma (PDAC) V Krishna, V Krishna, E Tiu, V Nimgaonkar, D Vrabac, K Smith, A Joshi, ... CANCER RESEARCH 82 (22), 28-29, 2022 | | 2022 |
Generalizing Abundancy Index to Gaussian Integers V Krishna arXiv preprint arXiv:2004.13487, 2020 | | 2020 |